Plasma p-tau231 and p-tau217 as state markers of amyloid-β pathology in preclinical Alzheimer’s diseaseMarta Milà‐Alomà, Kaj Blennow, Nicholas J. Ashton et al.|Nature Medicine|2022Cited by 349
Transitioning from cerebrospinal fluid to blood tests to facilitate diagnosis and disease monitoring in Alzheimer's diseaseDeborah O T Alawode, Henrik Zetterberg, Amanda Heslegrave et al.|Journal of Internal Medicine|2021Cited by 105
Biological variation estimates of Alzheimer's disease plasma biomarkers in healthy individualsWagner S. Brum, Kaj Blennow, Nicholas J. Ashton et al.|Alzheimer s & Dementia|2023Cited by 77
Biomarkers of Alzheimer's disease and neurodegeneration in dried blood spots—A new collection method for remote settingsHanna Huber, Laia Montoliu‐Gaya, Kaj Blennow et al.|Alzheimer s & Dementia|2024Cited by 44
Biomarker discovery in Alzheimer's and neurodegenerative diseases using Nucleic Acid Linked Immuno‐Sandwich AssayNicholas J. Ashton, Henrik Zetterberg, Andréa Lessa Benedet et al.|Alzheimer s & Dementia|2025Cited by 20